Authors:
BICKEL U
GRAVE B
KANG YS
DELREY A
VOIGT K
Citation: U. Bickel et al., NO INCREASE IN BLOOD-BRAIN-BARRIER PERMEABILITY AFTER INTRAPERITONEALINJECTION OF ENDOTOXIN IN THE RAT, Journal of neuroimmunology, 85(2), 1998, pp. 131-136
Citation: U. Bickel et al., DRUG-DELIVERY TO THE BRAIN - STABILITY OF A DISULFIDE LINKER IN A CHIMERIC PEPTIDE DURING TRANSPORT THROUGH ENDOTHELIAL-CELLS, Naunyn-Schmiedeberg's archives of pharmacology, 357(4), 1998, pp. 663-663
Citation: Df. Wu et al., BLOOD-BRAIN-BARRIER PERMEABILITY TO MORPHINE-6-GLUCURONIDE IS MARKEDLY REDUCED COMPARED WITH MORPHINE, Drug metabolism and disposition, 25(6), 1997, pp. 768-771
Authors:
BICKEL U
GRAVE B
DOMLING D
KANG YS
VOIGT K
Citation: U. Bickel et al., ROLE OF THE BLOOD-BRAIN-BARRIER IN INTERACTIONS BETWEEN THE IMMUNE-SYSTEM AND THE BRAIN - STUDIES WITH LIPOPOLYSACCHARIDE, INTERLEUKIN-1-ALPHA AND TUMOR-NECROSIS-FACTOR-ALPHA, Naunyn-Schmiedeberg's archives of pharmacology, 354(4), 1996, pp. 91-91
Citation: U. Bickel et al., POOR PERMEABILITY OF MORPHINE 3-GLUCURONIDE AND MORPHINE 6-GLUCURONIDE THROUGH THE BLOOD-BRAIN-BARRIER IN THE RAT, The Journal of pharmacology and experimental therapeutics, 278(1), 1996, pp. 107-113
Citation: U. Bickel et al., IN-VIVO CLEAVABILITY OF A DISULFIDE-BASED CHIMERIC OPIOID PEPTIDE IN RAT-BRAIN, Bioconjugate chemistry, 6(2), 1995, pp. 211-218
Authors:
BICKEL U
LEE VMY
TROJANOWSKI JQ
PARDRIDGE WM
Citation: U. Bickel et al., DEVELOPMENT AND IN-VITRO CHARACTERIZATION OF A CATIONIZED MONOCLONAL-ANTIBODY AGAINST BETA-A4 PROTEIN - A POTENTIAL PROBE FOR ALZHEIMERS-DISEASE, Bioconjugate chemistry, 5(2), 1994, pp. 119-125
Citation: U. Bickel et Wm. Pardridge, RAPID CLEAVAGE OF DISULFIDE-BASED CHIMERIC PEPTIDES BY RAT-BRAIN IN-VIVO, The FASEB journal, 8(5), 1994, pp. 10000626-10000626
Authors:
PARDRIDGE WM
BICKEL U
BUCIAK J
YANG J
DIAGNE A
AEPINUS C
Citation: Wm. Pardridge et al., CATIONIZATION OF A MONOCLONAL-ANTIBODY TO THE HUMAN-IMMUNODEFICIENCY-VIRUS REV PROTEIN ENHANCES CELLULAR UPTAKE BUT DOES NOT IMPAIR ANTIGEN-BINDING OF THE ANTIBODY, Immunology letters, 42(3), 1994, pp. 191-195
Citation: Ys. Kang et al., PHARMACOKINETICS AND SATURABLE BLOOD-BRAIN-BARRIER TRANSPORT OF BIOTIN BOUND TO A CONJUGATE OF AVIDIN AND A MONOCLONAL-ANTIBODY TO THE TRANSFERRIN RECEPTOR, Drug metabolism and disposition, 22(1), 1994, pp. 99-105
Citation: U. Bickel et al., SYNTHESIS AND BIOACTIVITY OF MONOBIOTINYLATED DALDA - A MU-SPECIFIC OPIOID PEPTIDE DESIGNED FOR TARGETED BRAIN DELIVERY, The Journal of pharmacology and experimental therapeutics, 268(2), 1994, pp. 791-796
Authors:
PARDRIDGE WM
BICKEL U
BUCIAK J
YANG J
DIAGNE A
Citation: Wm. Pardridge et al., ENHANCED ENDOCYTOSIS AND ANTI-HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ACTIVITY OF ANTI-REV ANTIBODIES AFTER CATIONIZATION, The Journal of infectious diseases, 169(1), 1994, pp. 55-61
Authors:
BICKEL U
KANG YS
YOSHIKAWA T
PARDRIDGE WM
Citation: U. Bickel et al., IN-VIVO DEMONSTRATION OF SUBCELLULAR-LOCALIZATION OF ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODY-COLLOIDAL GOLD CONJUGATE IN BRAIN CAPILLARY ENDOTHELIUM, The Journal of histochemistry and cytochemistry, 42(11), 1994, pp. 1493-1497
Authors:
BICKEL U
KANG YS
YOSHIKAWA T
PARDRIDGE WM
Citation: U. Bickel et al., IN-VIVO DEMONSTRATION OF SUBCELLULAR-LOCALIZATION OF ANTITRANSFERRIN RECEPTOR MONOCLONAL ANTIBODY-COLLOIDAL GOLD CONJUGATE IN BRAIN CAPILLARY ENDOTHELIUM, The Journal of histochemistry and cytochemistry, 42(11), 1994, pp. 1493-1497
Citation: A. Samii et al., BLOOD-BRAIN-BARRIER TRANSPORT OF NEUROPEPTIDES - ANALYSIS WITH A METABOLICALLY STABLE DERMORPHIN ANALOG, The American journal of physiology, 267(1), 1994, pp. 50000124-50000131
Citation: U. Bickel et al., DELIVERY OF PEPTIDES AND PROTEINS THROUGH THE BLOOD-BRAIN-BARRIER, Advanced drug delivery reviews, 10(2-3), 1993, pp. 205-245